Five Years of Managing Multidrug-Resistant Tuberculosis at PMDT Mardan: Treatment Outcomes, Challenges, and Key Insights
Journal of Bacha Khan Medical College · 06.01.2025 · 5 (02) · 235-239
DOI: 10.69830/1zszd349 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bacha Khan Medical College, online erschienen am 06.01.2025. Verfasst von Rumman und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Multidrug-resistant tuberculosis (MDR-TB) remains a global public health concern, particularly in low- and middle-income countries such as Pakistan.
Objective
This study aimed to evaluate treatment outcomes, challenges, and key lessons from five years of MDR-TB management at the Programmatic Management of Drug-Resistant Tuberculosis (PMDT) site, MTI Mardan. Methodology: A retrospective cohort of 161 patients with bacteriologically confirmed resistance to at least isoniazid and rifampicin was reviewed. Data were analyzed using SPSS v25.
Results
The treatment success rate was 85%, with 16% of patients showing poor outcomes (death, failure, or loss to follow-up). Adverse drug reactions (ADRs) occurred in 45%, mainly gastrointestinal intolerance, hepatotoxicity, and ototoxicity. Comorbidities such as diabetes mellitus (25%) and chronic lung disease (38%) were key determinants of outcome. Resistance to fluoroquinolones (35%) and second-line injectables (25%) was common. Predictors of poor outcomes included diabetes, fluoroquinolone resistance, multiple prior TB treatments, severe ADRs, malnutrition, and advanced age.
Conclusion
While the PMDT Mardan site achieved an encouraging success rate, challenges persist regarding ADRs, comorbidities, and drug resistance. Strengthened pharmacovigilance, individualized regimens, and multidisciplinary management are essential for optimizing outcomes.
Zitieren
APA
Rumman, Ali, S., Hussain, S., Ullah, U., & shah, A. A. (2025). Five Years of Managing Multidrug-Resistant Tuberculosis at PMDT Mardan: Treatment Outcomes, Challenges, and Key Insights. Journal of Bacha Khan Medical College, 5(02), 235-239. https://doi.org/10.69830/1zszd349
Vancouver
Rumman, Ali S, Hussain S, Ullah U, shah AA. Five Years of Managing Multidrug-Resistant Tuberculosis at PMDT Mardan: Treatment Outcomes, Challenges, and Key Insights. Journal of Bacha Khan Medical College. 2025;5(02):235-239. doi:10.69830/1zszd349
BibTeX
@article{Rumman2025,
author = {Rumman and Ali, Sajjad and Hussain, Shabir and Ullah, Ubaid and shah, Aleina ali},
title = {Five Years of Managing Multidrug-Resistant Tuberculosis at PMDT Mardan: Treatment Outcomes, Challenges, and Key Insights},
journal = {Journal of Bacha Khan Medical College},
year = {2025},
volume = {5},
number = {02},
pages = {235--239},
doi = {10.69830/1zszd349}
}
EUVIMED